Genmab A/S (GMAB) Announces Submissions of Regulatory Applications for Epcoritamab for Relapsed/Refractory LBCL and DLBCL

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. HOOD
10. IBM

Go back to Genmab A/S (GMAB) Announces Submissions of Regulatory Applications for Epcoritamab for Relapsed/Refractory LBCL and DLBCL
AbbVie (NYSE: ABBV) Delayed: 230.01 +13.52 (6.25%)
Previous Close $216.49    52 Week High $68.12 
Open $221.94    52 Week Low $50.71 
Day High $232.32    P/E 49.89 
Day Low $221.94    EPS $4.61 
Volume 9,705,442       

(NASDAQ: GMAB) Delayed: 25.61 +0.34 (1.35%)
Previous Close $25.27    52 Week High $ 
Open $25.05    52 Week Low $ 
Day High $25.66    P/E N/A 
Day Low $25.16    EPS $ 
Volume 1,592,899